Status:
COMPLETED
Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Cardiac Transplant Rejection
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Heart Transplant Rejection
Eligibility:
All Genders
Brief Summary
To find a non-invasive alternative (with using cardiac MRI) to invasive endomyocardial biopsies for serial detection (EMB) and follow-up of cellular rejection in heart transplant in childhood.
Detailed Description
Objectives To find a non-invasive alternative (with using cardiac MRI) to invasive endomyocardial biopsies for serial detection and follow-up of cellular rejection in heart transplant in childhood. B...
Eligibility Criteria
Inclusion
- all patients who had undergone cardiac transplants are eligible
Exclusion
- no consent
- allergy to contrast agent (Gadolinium)
- severe renal failure (clearance \< 30ml/min/1.73m²)
- claustrophobia
- severe arrhythmias
- absence of medical care insurance
- pregnancy
Key Trial Info
Start Date :
February 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01136135
Start Date
February 1 2010
End Date
February 1 2015
Last Update
September 1 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Necker
Paris, France, 75015